Cutler Group LP Lava Therapeutics Nv Put Options Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
Put Options
1 transactions
Others Institutions Holding LVTX
# of Institutions
23Shares Held
3.36MCall Options Held
100Put Options Held
200-
Redmile Group, LLC San Francisco, CA2.07MShares$2.78 Million0.16% of portfolio
-
Bruce & Co., Inc. Chicago, IL772KShares$1.03 Million0.33% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3126KShares$169,2790.03% of portfolio
-
Pathway Financial Advisors LLC103KShares$137,3500.02% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA65KShares$87,1000.0% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $34.6M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...